In addition, the application of TDP1 inhibitors has been explored in tumor resistant to TOP1 inhibitors, such as metastatic ovarian, cervical, and small-cell lung cancers (Hu et al, 2021). Here, TDP1 is linked to small cell lung carcinoma.